Cargando…
Duration for carrying SARS-CoV-2 in COVID-19 patients
Autores principales: | Du, Xinwei, Yu, Xue, Li, Qingqing, Li, Xianyang, Qin, Tao, Luo, Qiankun, Wang, Miaomiao, Jiang, Minlin, Bai, Li, Wang, Xiaoping, Pan, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195094/ https://www.ncbi.nlm.nih.gov/pubmed/32283161 http://dx.doi.org/10.1016/j.jinf.2020.03.053 |
Ejemplares similares
-
Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020) -
Potential infectious risk from the pets carrying SARS-CoV-2
por: Wang, Haizhou, et al.
Publicado: (2020) -
The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive
por: Zhao, Hong, et al.
Publicado: (2021) -
Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19)
por: Jiang, Minlin, et al.
Publicado: (2020) -
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
por: Ye, Miaomiao, et al.
Publicado: (2021)